Biotech · Private company
NovaDigm Therapeutics, Inc.
Track this companyFree. Adds NovaDigm Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- NDV-3APhase 2 · Staphylococcus AureusClinicalTrials.gov · fetched Nov 12, 2026
- NDV-3 vaccine with alum IMPhase 1 · Staphylococcal InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- NDV-3 vaccine without alum IDPhase 1 · Staphylococcal InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- NDV-3 vaccine without alum IMPhase 1 · Staphylococcal InfectionsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Evaluation of NDV-3A Vaccine in Preventing S. Aureus ColonizationPHASE2 · COMPLETED · started Jan 30, 2018ClinicalTrials.gov NCT03455309 · fetched Nov 12, 2026
- Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 VaccinePHASE1 · COMPLETED · started Sep 1, 2011ClinicalTrials.gov NCT01447407 · fetched Nov 12, 2026